Literature DB >> 11192644

Beta-blockers as first-line therapy for hypertension.

G A Heckman, A Papaioannou, W Parkinson, C A Patterson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11192644      PMCID： PMC80403     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  11 in total

1.  1999 Canadian recommendations for the management of hypertension. Task Force for the Development of the 1999 Canadian Recommendations for the Management of Hypertension.

Authors:  R D Feldman; N Campbell; P Larochelle; P Bolli; E D Burgess; S G Carruthers; J S Floras; R B Haynes; G Honos; F H Leenen; L A Leiter; A G Logan; M G Myers; J D Spence; K B Zarnke
Journal:  CMAJ       Date:  1999       Impact factor: 8.262

2.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Authors:  J A Staessen; R Fagard; L Thijs; H Celis; G G Arabidze; W H Birkenhäger; C J Bulpitt; P W de Leeuw; C T Dollery; A E Fletcher; F Forette; G Leonetti; C Nachev; E T O'Brien; J Rosenfeld; J L Rodicio; J Tuomilehto; A Zanchetti
Journal:  Lancet       Date:  1997-09-13       Impact factor: 79.321

3.  Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study.

Authors:  L Hansson; L H Lindholm; T Ekbom; B Dahlöf; J Lanke; B Scherstén; P O Wester; T Hedner; U de Faire
Journal:  Lancet       Date:  1999-11-20       Impact factor: 79.321

4.  Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

Authors:  B Dahlöf; L H Lindholm; L Hansson; B Scherstén; T Ekbom; P O Wester
Journal:  Lancet       Date:  1991-11-23       Impact factor: 79.321

5.  Calcium-channel blockers and cognitive function in elderly people: results from the Canadian Study of Health and Aging.

Authors:  C J Maxwell; D B Hogan; E M Ebly
Journal:  CMAJ       Date:  1999-09-07       Impact factor: 8.262

6.  Efficacy and safety of atenolol, enalapril, and isradipine in elderly hypertensive women.

Authors:  H M Perry; W D Hall; J R Benz; D W Bartels; J B Kostis; R R Townsend; D L Due; A Peng; M Sirgo
Journal:  Am J Med       Date:  1994-01       Impact factor: 4.965

7.  A randomized controlled trial of the effects of three antihypertensive agents on blood pressure control and quality of life in older women.

Authors:  W B Applegate; H L Phillips; H Schnaper; A M Shepherd; D Schocken; J C Luhr; G G Koch; G D Park
Journal:  Arch Intern Med       Date:  1991-09

8.  Population dose versus response of betaxolol and atenolol: a comparison of potency and variability.

Authors:  N C Sambol; L B Sheiner
Journal:  Clin Pharmacol Ther       Date:  1991-01       Impact factor: 6.875

9.  Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

Authors:  B J Materson; D J Reda; W C Cushman; B M Massie; E D Freis; M S Kochar; R J Hamburger; C Fye; R Lakshman; J Gottdiener
Journal:  N Engl J Med       Date:  1993-04-01       Impact factor: 91.245

Review 10.  Report of the Canadian Hypertension Society Consensus Conference: 4. Hypertension in the elderly.

Authors:  R A Reeves; J G Fodor; C I Gryfe; C Patterson; J D Spence
Journal:  CMAJ       Date:  1993-09-15       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.